BioNTech SE (WBO:BNTX)
€ 108.9 0.6 (0.55%) Market Cap: 26.09 Bil Enterprise Value: 9.63 Bil PE Ratio: 0 PB Ratio: 1.29 GF Score: 62/100

BioNTech SE at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 05:45PM GMT
Release Date Price: €142.6 (+1.28%)
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Great. Good morning, everyone. My name is Jess Fye. I'm the large cap biotech analyst at JPMorgan, and we're delighted to be continuing the conference today with BioNTech. (Operator Instructions) So with that, let me turn it over to BioNTech CEO, Ugur Sahin, for the presentation.

Ugur Sahin
BioNTech SE - Co-Founder, CEO & Chair of the Management Board

Yes. Thank you for joining us today, and thank you for the JPM team for inviting us here. It's a pleasure to present here. So first of all, the usual forward-looking statements and some safety information about our vaccine. I would like to start, again, as always, with our vision. Our vision is to harness the power of the immune system to fight human diseases. And in the last 3 years, we were encountered with a terrible pandemic, and we were able to respond to this pandemic with a life-saving vaccine. We were in this privileged situation based on 20 years of research based on preparedness and it shows what technology, science and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot